IT解决方案和嵌入式技术分销商Avnet已经签署了一项针对申请的许可协议Bio-Key International,Inc。将IBM中间件集成到Bio-Key的生物识别身份验证软件中。
该集成将有助于AVNET加速对美洲,EMEA和亚太地区各国的客户的销售。
这全球IBM应用程序特定许可计划根据IBM Solutions AVNET技术解决方案外部销售副总裁Mark Martin表示,将为AVNET的业务合作伙伴提供更快的市场途径,其解决方案(例如单次签名)构建的解决方案。
将解决方案嵌入IBM中间件中,消除了为客户的两个支持结构的复杂性,同时继续提供IBM支持服务的全部范围。
Bio-Key董事长兼首席执行官Mike DePasquale说:“ Bio-Key对我们与AVNET的关系以及与IBM世界一流的身份验证产品组合的关系感到非常热情。”
“Avnet's ASL Program is an IBM channel, administered by Avnet, which is aimed at increasing the revenues and profits from middleware usage for business partners who provide value-added solutions and services to their customers. This underscores the strength of our software integration relationships and since we now have executives from Avnet and IBM who are dedicated to our mutual success we believe it will create revenue potential in multiple vertical markets.”
先前报道的是,Bio-Key International,Inc。介绍了其最新的紧凑型USB触摸指纹读取器,ecoid,在华盛顿特区的Connect:ID Expo